Covid19 Clinical Trial
Official title:
Effects of Pilates Exercises on Core Stability After Recovery From COVID -19
| Verified date | October 2023 |
| Source | University of Jazan |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This study will be conducted in the Department of physical therapy, College of Applied Medical Sciences,Jazan University, to Effects of Pilates Exercises on core stability after Recovery from COVID - 19
| Status | Completed |
| Enrollment | 145 |
| Est. completion date | February 23, 2023 |
| Est. primary completion date | October 24, 2022 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 19 Years to 26 Years |
| Eligibility | Inclusion Criteria: 1. Persons who had mild to moderate covid- 19 illness. 2. Asymptomatic period of at least seven days (without chest pain, breathlessness). 3. No musculoskeletal damage. 4. No pregnancy. 5. No visually identified asymmetries in the spinal trunk and lower limbs. 6. None of the subjects has a history of balance training 7. Subjects will not have any diseases of the central nervous system. 8. Subjects with body mass index (BMI)<25 kg/m2. Exclusion Criteria: 1. Persons who had more severe covid 19 illnesses and were hospitalized. 2. Persons who had during their illness chest pain breathlessness, palpitation, symptoms, and signs of heart failure. 9. Subjects with cardiopulmonary disorders. 3. A history of previous back or abdominal surgery/injury 4. Evidence of a systemic or musculoskeletal disease within the past six months - |
| Country | Name | City | State |
|---|---|---|---|
| Saudi Arabia | Jazan University | Riyadh | Jazan |
| Lead Sponsor | Collaborator |
|---|---|
| University of Jazan |
Saudi Arabia,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Evaluation of core stability: endurance capacity of anterior deep trunk muscles | Abdominal fatigue test: is an isometric trunk flexor test | at the date of the first session and at the last session after 12 weeks | |
| Primary | Evaluation of core stability: assesses the functioning of trunk extensor muscles | Sorensen back-extension endurance | at the date of the first session and at the last session after 12 weeks | |
| Primary | Evaluation of core stability: Prone Plank test | Prone Plank test | at the date of the first session and at the last session after 12 weeks | |
| Primary | Evaluation of core stability: Endurance capacity of lateral core muscles particularly the quadrates lumborum | Side Plank Tests | at the date of the first session and at the last session after 12 weeks | |
| Primary | Evaluation of core stability: balance test by Prokin system for perimeter parameter with opened eyes, measured in mm | Eyes Open perimeter (EOPM), measured in mm | 30 seconds | |
| Primary | Evaluation of core stability: balance test by Prokin system for perimeter parameter with closed eyes, measured in mm | Eyes closed perimeter (ECPM), measured in mm | 30 seconds | |
| Primary | Evaluation of core stability: balance test by Prokin system for ellipse area parameter with Opened eyes, measured in mm | Eyes Open ellipse area (EOEA) measured in mm2 | 30 seconds | |
| Primary | Evaluation of core stability: balance test by Prokin system for ellipse area parameter with closed eyes, measured in mm | Eyes closed ellipse area (ECEA) measured in mm2 | 30 seconds |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05047692 -
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04395768 -
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19
|
Phase 2 | |
| Terminated |
NCT04555096 -
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
|
Phase 2 | |
| Completed |
NCT04508777 -
COVID SAFE: COVID-19 Screening Assessment for Exposure
|
||
| Completed |
NCT04506268 -
COVID-19 SAFE Enrollment
|
N/A | |
| Completed |
NCT04961541 -
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04546737 -
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients
|
N/A | |
| Not yet recruiting |
NCT04543006 -
Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19
|
N/A | |
| Completed |
NCT04532294 -
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants
|
Phase 1 | |
| Terminated |
NCT04581915 -
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
|
Phase 2/Phase 3 | |
| Completed |
NCT04494646 -
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)
|
Phase 2 | |
| Terminated |
NCT04542993 -
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy
|
Phase 2 | |
| Not yet recruiting |
NCT04527211 -
Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel
|
Phase 3 | |
| Completed |
NCT04387292 -
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04537663 -
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
|
Phase 4 | |
| Not yet recruiting |
NCT05038449 -
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
|
N/A | |
| Completed |
NCT04979858 -
Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask
|
N/A | |
| Completed |
NCT04610502 -
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients
|
Phase 2 | |
| Active, not recruiting |
NCT06042855 -
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
|
Phase 3 |